DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma
KEYTRUDA is now approved for 14 indications across eight tumour types in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
MSD India
DCGI approves MSD India’s Keytruda for treating cervical and esophageal cancers
Keytruda is now approved for 10 indications in six different types of cancers in India
MSD India appoints Bhargavi Kakunuri as HR lead
Bhargavi will report to Noora Alsagoff, Head, Human Resources, MSD Asia Pacific, responsible for developing and implementing the…
NLEM 2020: Should patented drugs be included in it?
At the National Consultation Stakeholders meeting held in August for the revision of NLEM 2015, industry stakeholders requested…